Breast cancer gene BRCA1 may be involved in Alzheimer's disease
12/01/2015

Brain accumulation of beta-amyloid protein in Alzheimer's disease may cause impairments by depleting levels of a DNA repair protein produced by the breast cancer gene BRCA1.

Horizon Pharma plc receives European Commission approval for RAVICTIi oral liquid for the treatment of urea cycle disorder
12/01/2015

Horizon Pharma plc, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address...

Female hormone supplements with estrogen and progestin linked to breast cancer risk
12/01/2015

Postmenopausal African American women who use female hormone supplements containing estrogen and progestin ("combination" therapy) are at an increased risk for estrogen receptor positive breast...

Study offers insights to how ovarian cancer grows -- and potential to stop it
12/01/2015

Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both.

Lower survival rates in women with breast cancer diagnosed with depression
12/01/2015

Women with breast cancer who subsequently had a recorded diagnosis of depression had a 45% higher risk of death from all causes, according to a study led by King's College London.

Study offers insights to how ovarian cancer grows -- and potential to stop it
12/01/2015

Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both.

Can the oxygen in the blood be measured if the nails have been painted?
12/01/2015

A study by the UPV/EHU-University of the Basque Country indicates that the slight alteration in a pulse oximeter reading caused by nail varnish is clinically irrelevant.

FDA approves Empliciti, a new immune-stimulating therapy to treat multiple myeloma
11/30/2015

The U.S. Food and Drug Administration has granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three...

Obesity not a factor in racial/ethnic variation in cancer screening compliance
11/30/2015

The higher rate of cancer-related deaths among racial minorities has often been attributed to disparities in cancer screening compliance, however, a new study did not find that the association...

Benign prostatic hyperplasia treatment with new physiotherapeutic device
11/30/2015

A peer-reviewed article, "Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device," written by Dr. Simon Allen and Prof.